Growth Hormone
MGF
A mechanically-induced splice variant of IGF-1 with a unique C-terminal peptide investigated for activating muscle satellite cells in response to local tissue damage.
Also known as: Mechano Growth Factor, IGF-1Ec
Quick facts
Molecular weight
2,867 Da
Half-life
0.12 h
Frequency
daily
Admins / wk
7
Routes
SubQ / IM
Typical dose
200 mcg–400 mcg
Mechanism & positioning
A mechanically-induced splice variant of IGF-1 with a unique C-terminal peptide investigated for activating muscle satellite cells in response to local tissue damage.
Researched for: satellite cell activation, localised muscle repair.
Reconstitution defaults
Default vial
5 mg
BAC water
2 mL
Concentration
2500 mcg/mL
Doses per vial
~25
Calculate with this peptide
Documented pairwise interactions
References
- Goldspink G, Physiology, 2005.
Related peptides in the Growth Hormone class
CJC-1295 (no-DAC)
A growth-hormone-releasing-hormone analog researched for its ability to stimulate endogenous pulsatile GH secretion, often paired with a GHRP.
CJC-1295 (with DAC)
CJC-1295 conjugated to a Drug Affinity Complex linker that binds serum albumin, extending half-life to roughly eight days and producing a steady GHRH-axis baseline rather than pulsatile peaks.
Ipamorelin
A selective ghrelin-mimetic pentapeptide investigated for triggering GH release with minimal off-target hormonal effects.
Tesamorelin
A stabilised GHRH analog researched extensively in HIV-associated lipodystrophy for its visceral-fat-reducing properties.
Sermorelin
The original 1-29 amino-acid fragment of GHRH; researched for restoring pulsatile growth-hormone secretion via direct hypothalamic-pituitary axis stimulation.
Hexarelin
A six-amino-acid growth-hormone-releasing peptide investigated for potent acute GH release and ancillary cardiovascular research models.